PTJ
MEDP icon

Paul Tudor Jones’s Medpace MEDP Stock Holding History

Paul Tudor Jones’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-900
Closed -$299K – 3403
2024
Q4 		$299K Buy
900
+100
+13% +$33.9K ﹤0.01% 2582
2024
Q3 		$267K Buy
+800
New +$304K ﹤0.01% 2382
2024
Q2 		– Sell
-3,900
Closed -$1.58M – 2599
2024
Q1 		$1.58M Buy
+3,900
New +$1.37M 0.01% 1138
2023
Q4 		– Sell
-1,300
Closed -$315K – 2672
2023
Q3 		$315K Buy
+1,300
New +$332K ﹤0.01% 1906
2023
Q1 		– Sell
-2,600
Closed -$551K – 2748
2022
Q4 		$551K Buy
+2,600
New +$519K 0.01% 1516

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Paul Tudor Jones's MEDP Position: Q2 2026 in Review

Paul Tudor Jones sold out of Medpace (MEDP) in Q2 2026, closing a stake of 8,699 shares — an estimated $4.18M sold.

Paul Tudor Jones first reported a position in MEDP in Q3 2016 and held it in 21 quarters. The position peaked at $50.1M in Q4 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Paul Tudor Jones reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 8,699 Medpace shares in Q2 2026, an estimated $4.18M.
  • Paul Tudor Jones first reported a position in Medpace in Q3 2016 and held it in 21 quarters.
  • Paul Tudor Jones's Medpace position peaked at $50.1M in Q4 2025.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.